It has been evaluated in controlled human trials using disease-specific endpoints, with published clinical safety data
BPC-157 accelerates the healing of various tissues by promoting angiogenesis (new blood vessel formation) and increasing collagen production
overwhelming this clearance pathway leads to hepatic accumulation resembling the pathology of Wilsons disease
Whereas initial studies suggest that its expression in the proximal tubules is very low, recent studies using microdissected, freshly-isolated, murine, nephronic segments demonstrated the highest IGF-1R mRNA expression in proximal tubules along the nephron [11]
Where can I read about GHK-Cu evidence, safety, and COAs
Furthermore, BPC-157 has been shown to accelerate wound closure in the alkali-burn rat model